311 related articles for article (PubMed ID: 17011908)
21. Phthalates inhibit tamoxifen-induced apoptosis in MCF-7 human breast cancer cells.
Kim IY; Han SY; Moon A
J Toxicol Environ Health A; 2004 Dec; 67(23-24):2025-35. PubMed ID: 15513900
[TBL] [Abstract][Full Text] [Related]
22. Sequential combination chemotherapy in human breast cancer: a basis for increased antineoplastic activity and bone marrow protection.
Davis JH; Desoto JA; Fryar EB; Southerland WM; Bowen D
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(3):18-26. PubMed ID: 17531145
[TBL] [Abstract][Full Text] [Related]
23. The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha.
Tonetti DA; Zhang Y; Zhao H; Lim SB; Constantinou AI
Nutr Cancer; 2007; 58(2):222-9. PubMed ID: 17640169
[TBL] [Abstract][Full Text] [Related]
24. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
Hatkevich T; Ramos J; Santos-Sanchez I; Patel YM
Exp Cell Res; 2014 Oct; 327(2):331-9. PubMed ID: 24881818
[TBL] [Abstract][Full Text] [Related]
25. Antiproliferation and apoptosis induced by tamoxifen in human bile duct carcinoma QBC939 cells via upregulated p53 expression.
Han P; Kang JH; Li HL; Hu SX; Lian HH; Qiu PP; Zhang J; Li WG; Chen QX
Biochem Biophys Res Commun; 2009 Jul; 385(2):251-6. PubMed ID: 19460356
[TBL] [Abstract][Full Text] [Related]
26. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.
Kim CG; Choi BH; Son SW; Yi SJ; Shin SY; Lee YH
Cell Signal; 2007 Jun; 19(6):1290-300. PubMed ID: 17307334
[TBL] [Abstract][Full Text] [Related]
27. [Effects of tamoxifen on apoptosis and matrix metalloproteinase-7 expression in estrogen receptor beta-positive colonic cancer cell line HT-29].
Fang YJ; Wang GQ; Lu ZH; Zhang LY; Pan ZZ; Zhou ZW; Wan DS
Ai Zheng; 2008 Nov; 27(11):1172-6. PubMed ID: 19000448
[TBL] [Abstract][Full Text] [Related]
28. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
Liang Y; Hou M; Kallab AM; Barrett JT; El Etreby F; Schoenlein PV
Int J Oncol; 2003 Aug; 23(2):369-80. PubMed ID: 12851686
[TBL] [Abstract][Full Text] [Related]
29. The DNA-damaging potential of tamoxifen in breast cancer and normal cells.
Wozniak K; Kolacinska A; Blasinska-Morawiec M; Morawiec-Bajda A; Morawiec Z; Zadrozny M; Blasiak J
Arch Toxicol; 2007 Jul; 81(7):519-27. PubMed ID: 17593413
[TBL] [Abstract][Full Text] [Related]
30. Protein tyrosine kinase, JNK, and ERK involvement in pseudolaric acid B-induced apoptosis of human breast cancer MCF-7 cells.
Yu JH; Wang HJ; Li XR; Tashiro S; Onodera S; Ikejima T
Acta Pharmacol Sin; 2008 Sep; 29(9):1069-76. PubMed ID: 18718176
[TBL] [Abstract][Full Text] [Related]
31. The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells.
Horii Y; Takei H; Koibuchi Y; Horiguchi J; Maemura M; Iino Y; Morishita Y
Oncol Rep; 2006 May; 15(5):1191-5. PubMed ID: 16596185
[TBL] [Abstract][Full Text] [Related]
32. Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells.
Kurebayashi J; Nukatsuka M; Nagase H; Nomura T; Hirono M; Yamamoto Y; Sugimoto Y; Oka T; Sonoo H
Cancer Chemother Pharmacol; 2007 Mar; 59(4):515-25. PubMed ID: 16900372
[TBL] [Abstract][Full Text] [Related]
33. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
[TBL] [Abstract][Full Text] [Related]
34. Tamoxifen modulates apoptotic pathways in primary endometrial cell cultures.
Stackievicz R; Drucker L; Radnay J; Beyth Y; Yarkoni S; Cohen I
Clin Cancer Res; 2001 Feb; 7(2):415-20. PubMed ID: 11234898
[TBL] [Abstract][Full Text] [Related]
35. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D, tamoxifen and beta-estradiol modulate breast cancer cell growth and interleukin-6 and metalloproteinase-2 production in three-dimensional co-cultures of tumor cell spheroids with endothelium.
Paduch R; Kandefer-Szerszeń M
Cell Biol Toxicol; 2005; 21(5-6):247-56. PubMed ID: 16323060
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment.
Marcsek Z; Kocsis Z; Jakab M; Szende B; Tompa A
Cancer Biother Radiopharm; 2004 Dec; 19(6):746-53. PubMed ID: 15665622
[TBL] [Abstract][Full Text] [Related]
38. Modulation of epirubicin cytotoxicity by tamoxifen in human breast cancer cell lines.
Azab SS; El-Demerdash E; Abdel-Naim AB; Youssef E; El-Sharkawy N; Osman AM
Biochem Pharmacol; 2005 Sep; 70(5):725-32. PubMed ID: 16005435
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis induced by diallyl disulfide in human breast cancer cell line MCF-7.
Lei XY; Yao SQ; Zu XY; Huang ZX; Liu LJ; Zhong M; Zhu BY; Tang SS; Liao DF
Acta Pharmacol Sin; 2008 Oct; 29(10):1233-9. PubMed ID: 18817629
[TBL] [Abstract][Full Text] [Related]
40. Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen.
Zheng A; Kallio A; Härkönen P
Endocrinology; 2007 Jun; 148(6):2764-77. PubMed ID: 17363451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]